Abstract

Prominent endosomal and lysosomal changes are an invariant feature of neurons in sporadic Alzheimer's disease (AD). These changes include increased levels of lysosomal hydrolases in early endosomes and increased expression of the cation-dependent mannose 6-phosphate receptor (CD-MPR), which is partially localized to early endosomes. To determine whether AD-associated redistribution of lysosomal hydrolases resulting from changes in CD-MPR expression affects amyloid precursor protein (APP) processing, we stably transfected APP-overexpressing murine L cells with human CD-MPR. As controls for these cells, we also expressed CD-MPR trafficking mutants that either localize to the plasma membrane (CD-MPRpm) or to early endosomes (CD-MPRendo). Expression of CD-MPR resulted in a partial redistribution of a representative lysosomal hydrolase, cathepsin D, to early endosomal compartments. Turnover of APP and secretion of sAPPalpha and sAPPbeta were not altered by overexpression of any of the CD-MPR constructs. However, secretion of both human Abeta40 and Abeta42 into the growth media nearly tripled in CD-MPR- and CD-MPRendo-expressing cells when compared with parental or CD-MPRpm-expressing cells. Comparable increases were confirmed for endogenous mouse Abeta40 in L cells expressing these CD-MPR constructs but not overexpressing human APP. These data suggest that redistribution of lysosomal hydrolases to early endocytic compartments mediated by increased expression of the CD-MPR may represent a potentially pathogenic mechanism for accelerating Abeta generation in sporadic AD, where the mechanism of amyloidogenesis is unknown.

Highlights

  • Prominent endosomal and lysosomal changes are an invariant feature of neurons in sporadic Alzheimer’s disease (AD)

  • Lysosomal system activation, which develops in virtually all neurons within cell populations that are potentially vulnerable to the disease process, is characterized precursor protein; soluble APP fragments (sAPP), soluble amyloid precursor protein (APP); Cat D, cathepsin D; mannose 6-phosphate receptors (MPR), mannose 6-phosphate receptor; CD-MPR, cation-dependent mannose 6-phosphate receptor; cation-independent MPR (CI-MPR), cation-independent mannose 6-phosphate receptor; EEA1, early endosome antigen 1; ELISA, enzymelinked immunosorbent assay; HA, hemagglutinin; BACE, beta-site APP-cleaving enzyme

  • We modeled the alterations in hydrolase trafficking we had observed in sporadic AD brain by reproducing in a cell line the increased CD-MPR expression seen in the disease [9]

Read more

Summary

Introduction

Prominent endosomal and lysosomal changes are an invariant feature of neurons in sporadic Alzheimer’s disease (AD). To determine whether AD-associated redistribution of lysosomal hydrolases resulting from changes in CD-MPR expression affects amyloid precursor protein (APP) processing, we stably transfected APP-overexpressing murine L cells with human CDMPR. As controls for these cells, we expressed CDMPR trafficking mutants that either localize to the plasma membrane (CD-MPRpm) or to early endosomes (CD-MPRendo). Comparable increases were confirmed for endogenous mouse A␤40 in L cells expressing these CD-MPR constructs but not overexpressing human APP These data suggest that redistribution of lysosomal hydrolases to early endocytic compartments mediated by increased expression of the CD-MPR may represent a potentially pathogenic mechanism for accelerating A␤ generation in sporadic AD, where the mechanism of amyloidogenesis is unknown. Cat D levels in the cerebrospinal fluid are increased in individuals with sporadic AD, suggesting that changes in the intracellular trafficking of lysosomal enzymes result in their abnormal accumulation within early endosomes and in their secretion from neurons [15]

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call